Expanding Immunotherapy in Early-Stage HR+ and TNBC – Medscape

  1. Expanding Immunotherapy in Early-Stage HR+ and TNBC  Medscape
  2. Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial  Nature
  3. Cellular…

Continue Reading